Thyroid hormone promotes remodeling of coronary resistance vessels

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Savinova, Olga V ^a   Liu, Yingheng ^a   Aasen, Garth A ^a   Mao, Kai ^a   Weltman, Nathan Y ^a   Nedich, Brett L ^a   Liang, Qiangrong ^a   Gerdes, A Martin ^a,b  

^a UNIVERSITY OF SOUTH DAKOTA   (United States)

^b NEW YORK INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; LIOTHYRONINE; ANGIOPOIETIN; THYROID HORMONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY DENSITY; CELL ACTIVITY; CONTROLLED STUDY; CORONARY VASCULAR RESISTANCE; DRUG MECHANISM; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HEART LEFT VENTRICLE MUSCLE; HORMONE ACTION; HYPOTHYROIDISM; MALE; MICROVASCULATURE; MUSCLE ATROPHY; MUSCLE DEVELOPMENT; NONHUMAN; RAT; THYROIDECTOMY; TREATMENT DURATION; ANIMAL; CELL PROLIFERATION; CORONARY BLOOD VESSEL; CYTOLOGY; DISEASE MODEL; ECHOCARDIOGRAPHY; FLUORESCENCE MICROSCOPY; HEART FAILURE; HEART MUSCLE; METABOLISM; METHODOLOGY; PATHOPHYSIOLOGY; PHENOTYPE; TIME; VASCULAR RESISTANCE; VASCULAR SMOOTH MUSCLE;

RATTUS;

ANGIOPOIETINS; ANIMALS; CELL PROLIFERATION; CORONARY VESSELS; DISEASE MODELS, ANIMAL; ECHOCARDIOGRAPHY; GENE EXPRESSION REGULATION; HEART FAILURE; HYPOTHYROIDISM; MICROSCOPY, FLUORESCENCE; MUSCLE, SMOOTH, VASCULAR; MYOCARDIUM; PHENOTYPE; RATS; THYROID HORMONES; THYROIDECTOMY; TIME FACTORS; TRIIODOTHYRONINE; VASCULAR RESISTANCE;

EID: 80053071142     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0025054     Document Type: Article

References (34)

1. Klein I, Ojamaa K, (2001) Thyroid hormone and the cardiovascular system. N Engl J Med 344: 501-509.
2. Tang YD, Kuzman JA, Said S, Anderson BE, Wang X, et al. (2005) Low thyroid function leads to cardiac atrophy with chamber dilatation, impaired myocardial blood flow, loss of arterioles, and severe systolic dysfunction. Circulation 112: 3122-3130.
3. Asvold BO, Bjoro T, Nilsen TI, Gunnell D, Vatten LJ, (2008) Thyrotropin levels and risk of fatal coronary heart disease: the HUNT study. Arch Intern Med 168: 855-860.
4. Asvold BO, Vatten LJ, Nilsen TI, Bjoro T, (2007) The association between TSH within the reference range and serum lipid concentrations in a population-based study. The HUNT Study. Eur J Endocrinol 156: 181-186.
5. Gerdes AM, Iervasi G, (2010) Thyroid replacement therapy and heart failure. Circulation 122: 385-393.
6. Khalife WI, Tang YD, Kuzman JA, Thomas TA, Anderson BE, et al. (2005) Treatment of subclinical hypothyroidism reverses ischemia and prevents myocyte loss and progressive LV dysfunction in hamsters with dilated cardiomyopathy. Am J Physiol Heart Circ Physiol 289: H2409-2415.
7. Thomas TA, Kuzman JA, Anderson BE, Andersen SM, Schlenker EH, et al. (2005) Thyroid hormones induce unique and potentially beneficial changes in cardiac myocyte shape in hypertensive rats near heart failure. Am J Physiol Heart Circ Physiol 288: H2118-2122.
8. Pantos C, Mourouzis I, Markakis K, Tsagoulis N, Panagiotou M, et al. (2008) Long-term thyroid hormone administration reshapes left ventricular chamber and improves cardiac function after myocardial infarction in rats. Basic Res Cardiol 103: 308-318.
9. Henderson KK, Danzi S, Paul JT, Leya G, Klein I, et al. (2009) Physiological replacement of T3 improves left ventricular function in an animal model of myocardial infarction-induced congestive heart failure. Circ Heart Fail 2: 243-252.
10. Liu Y, Redetzke RA, Said S, Pottala JV, de Escobar GM, et al. (2008) Serum thyroid hormone levels may not accurately reflect thyroid tissue levels and cardiac function in mild hypothyroidism. Am J Physiol Heart Circ Physiol 294: H2137-2143.
11. Adair TH, Wells ML, Hang J, Montani JP, (1994) A stereological method for estimating length density of the arterial vascular system. Am J Physiol 266: H1434-1438.
12. Liu Y, Wang D, Redetzke RA, Sherer BA, Gerdes AM, (2009) Thyroid analogue 3,5-diiodothyropropionic acid (DITPA) promotes healthy vasculature in adult myocardium independent of thyroid effects on cardiac function. Am J Physiol Heart Circ Physiol.
13. Price RJ, Owens GK, Skalak TC, (1994) Immunohistochemical identification of arteriolar development using markers of smooth muscle differentiation. Evidence that capillary arterialization proceeds from terminal arterioles. Circ Res 75: 520-527.
14. Tomanek RJ, Busch TL, (1998) Coordinated capillary and myocardial growth in response to thyroxine treatment. Anat Rec 251: 44-49.
15. Tomanek RJ, Zimmerman MB, Suvarna PR, Morkin E, Pennock GD, et al. (1998) A thyroid hormone analog stimulates angiogenesis in the post-infarcted rat heart. J Mol Cell Cardiol 30: 923-932.
16. Wang X, Zheng W, Christensen LP, Tomanek RJ, (2003) DITPA stimulates bFGF, VEGF, angiopoietin, and Tie-2 and facilitates coronary arteriolar growth. Am J Physiol Heart Circ Physiol 284: H613-618.
17. Zheng W, Weiss RM, Wang X, Zhou R, Arlen AM, et al. (2004) DITPA stimulates arteriolar growth and modifies myocardial postinfarction remodeling. Am J Physiol Heart Circ Physiol 286: H1994-2000.
18. Tomanek RJ, Doty MK, Sandra A, (1998) Early coronary angiogenesis in response to thyroxine: growth characteristics and upregulation of basic fibroblast growth factor. Circ Res 82: 587-593.
19. Liu Y, Sherer BA, Redetzke RA, Gerdes AM, (2010) Regulation of arteriolar density in adult myocardium during low thyroid conditions. Vascul Pharmacol 52: 146-150.
20. Morreale de Escobar G, Calvo R, Escobar del Rey F, Obregon MJ, (1994) Thyroid hormones in tissues from fetal and adult rats. Endocrinology 134: 2410-2415.
21. Heron MI, Rakusan K, (1995) Proliferating cell nuclear antigen (PCNA) detection of cellular proliferation in hypothyroid and hyperthyroid rat hearts. J Mol Cell Cardiol 27: 1393-1403.
22. van Groningen JP, Wenink AC, Testers LH, (1991) Myocardial capillaries: increase in number by splitting of existing vessels. Anat Embryol (Berl) 184: 65-70.
23. Kawai-Kowase K, Owens GK, (2007) Multiple repressor pathways contribute to phenotypic switching of vascular smooth muscle cells. Am J Physiol Cell Physiol 292: C59-69.
24. Davis FB, Mousa SA, O'Connor L, Mohamed S, Lin HY, et al. (2004) Proangiogenic action of thyroid hormone is fibroblast growth factor-dependent and is initiated at the cell surface. Circ Res 94: 1500-1506.
25. Mousa SA, O'Connor L, Davis FB, Davis PJ, (2006) Proangiogenesis action of the thyroid hormone analog 3,5-diiodothyropropionic acid (DITPA) is initiated at the cell surface and is integrin mediated. Endocrinology 147: 1602-1607.
26. Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, et al. (1997) Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277: 55-60.
27. Davis S, Aldrich TH, Jones PF, Acheson A, Compton DL, et al. (1996) Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 87: 1161-1169.
28. Suri C, Jones PF, Patan S, Bartunkova S, Maisonpierre PC, et al. (1996) Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87: 1171-1180.
29. Thurston G, Wang Q, Baffert F, Rudge J, Papadopoulos N, et al. (2005) Angiopoietin 1 causes vessel enlargement, without angiogenic sprouting, during a critical developmental period. Development 132: 3317-3326.
30. Shyu KG, Manor O, Magner M, Yancopoulos GD, Isner JM, (1998) Direct intramuscular injection of plasmid DNA encoding angiopoietin-1 but not angiopoietin-2 augments revascularization in the rabbit ischemic hindlimb. Circulation 98: 2081-2087.
31. Lei L, Zhou R, Zheng W, Christensen LP, Weiss RM, et al. (2004) Bradycardia induces angiogenesis, increases coronary reserve, and preserves function of the postinfarcted heart. Circulation 110: 796-802.
32. Stolen KQ, Kemppainen J, Kalliokoski KK, Karanko H, Toikka J, et al. (2004) Myocardial perfusion reserve and peripheral endothelial function in patients with idiopathic dilated cardiomyopathy. Am J Cardiol 93: 64-68.
33. Neglia D, Michelassi C, Trivieri MG, Sambuceti G, Giorgetti A, et al. (2002) Prognostic role of myocardial blood flow impairment in idiopathic left ventricular dysfunction. Circulation 105: 186-193.
34. Roura S, Bayes-Genis A, (2009) Vascular dysfunction in idiopathic dilated cardiomyopathy. Nat Rev Cardiol 6: 590-598.